BIOMAT Database Logo BIOMAT Database Logo

Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen. 2008

Antoni Hurtado, and Kelly A Holmes, and Timothy R Geistlinger, and Iain R Hutcheson, and Robert I Nicholson, and Myles Brown, and Jie Jiang, and William J Howat, and Simak Ali, and Jason S Carroll
Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.

Crosstalk between the oestrogen receptor (ER) and ERBB2/HER-2 pathways has long been implicated in breast cancer aetiology and drug response, yet no direct connection at a transcriptional level has been shown. Here we show that oestrogen-ER and tamoxifen-ER complexes directly repress ERBB2 transcription by means of a cis-regulatory element within the ERBB2 gene in human cell lines. We implicate the paired box 2 gene product (PAX2), in a previously unrecognized role, as a crucial mediator of ER repression of ERBB2 by the anti-cancer drug tamoxifen. We show that PAX2 and the ER co-activator AIB-1/SRC-3 compete for binding and regulation of ERBB2 transcription, the outcome of which determines tamoxifen response in breast cancer cells. The repression of ERBB2 by ER-PAX2 links these two breast cancer subtypes and suggests that aggressive ERBB2-positive tumours can originate from ER-positive luminal tumours by circumventing this repressive mechanism. These data provide mechanistic insight into the molecular basis of endocrine resistance in breast cancer.

UI MeSH Term Description Entries
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D012045 Regulatory Sequences, Nucleic Acid Nucleic acid sequences involved in regulating the expression of genes. Nucleic Acid Regulatory Sequences,Regulatory Regions, Nucleic Acid (Genetics),Region, Regulatory,Regions, Regulatory,Regulator Regions, Nucleic Acid,Regulatory Region,Regulatory Regions
D012097 Repressor Proteins Proteins which maintain the transcriptional quiescence of specific GENES or OPERONS. Classical repressor proteins are DNA-binding proteins that are normally bound to the OPERATOR REGION of an operon, or the ENHANCER SEQUENCES of a gene until a signal occurs that causes their release. Repressor Molecules,Transcriptional Silencing Factors,Proteins, Repressor,Silencing Factors, Transcriptional
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004967 Estrogens Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. Estrogen,Estrogen Effect,Estrogen Effects,Estrogen Receptor Agonists,Estrogenic Agents,Estrogenic Compounds,Estrogenic Effect,Estrogenic Effects,Agents, Estrogenic,Agonists, Estrogen Receptor,Compounds, Estrogenic,Effects, Estrogen,Effects, Estrogenic,Receptor Agonists, Estrogen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013629 Tamoxifen One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM. ICI-46,474,ICI-46474,ICI-47699,Nolvadex,Novaldex,Soltamox,Tamoxifen Citrate,Tomaxithen,Zitazonium,Citrate, Tamoxifen,ICI 46,474,ICI 46474,ICI 47699,ICI46,474,ICI46474,ICI47699
D015534 Trans-Activators Diffusible gene products that act on homologous or heterologous molecules of viral or cellular DNA to regulate the expression of proteins. Nuclear Trans-Acting Factor,Trans-Acting Factors,Trans-Acting Factor,Trans-Activator,Transactivator,Transactivators,Factor, Nuclear Trans-Acting,Factor, Trans-Acting,Factors, Trans-Acting,Nuclear Trans Acting Factor,Trans Acting Factor,Trans Acting Factors,Trans Activator,Trans Activators,Trans-Acting Factor, Nuclear
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic

Related Publications

Antoni Hurtado, and Kelly A Holmes, and Timothy R Geistlinger, and Iain R Hutcheson, and Robert I Nicholson, and Myles Brown, and Jie Jiang, and William J Howat, and Simak Ali, and Jason S Carroll
Quantitative measures of oestrogen receptor and ERBB2 expression.
March 2007, The Lancet. Oncology,
Antoni Hurtado, and Kelly A Holmes, and Timothy R Geistlinger, and Iain R Hutcheson, and Robert I Nicholson, and Myles Brown, and Jie Jiang, and William J Howat, and Simak Ali, and Jason S Carroll
BASP1 interacts with oestrogen receptor α and modifies the tamoxifen response.
May 2017, Cell death & disease,
Antoni Hurtado, and Kelly A Holmes, and Timothy R Geistlinger, and Iain R Hutcheson, and Robert I Nicholson, and Myles Brown, and Jie Jiang, and William J Howat, and Simak Ali, and Jason S Carroll
Androgen receptor expression predicts beneficial tamoxifen response in oestrogen receptor-α-negative breast cancer.
February 2016, British journal of cancer,
Antoni Hurtado, and Kelly A Holmes, and Timothy R Geistlinger, and Iain R Hutcheson, and Robert I Nicholson, and Myles Brown, and Jie Jiang, and William J Howat, and Simak Ali, and Jason S Carroll
Modification of the rat uterine response to oestrogen and tamoxifen by thromboxane antagonists.
March 1991, British journal of pharmacology,
Antoni Hurtado, and Kelly A Holmes, and Timothy R Geistlinger, and Iain R Hutcheson, and Robert I Nicholson, and Myles Brown, and Jie Jiang, and William J Howat, and Simak Ali, and Jason S Carroll
AP-2 transcription factors in the regulation of ERBB2 gene transcription by oestrogen.
January 2000, Oncogene,
Antoni Hurtado, and Kelly A Holmes, and Timothy R Geistlinger, and Iain R Hutcheson, and Robert I Nicholson, and Myles Brown, and Jie Jiang, and William J Howat, and Simak Ali, and Jason S Carroll
Tamoxifen, screening and new oestrogen receptor modulators.
June 2001, Best practice & research. Clinical obstetrics & gynaecology,
Antoni Hurtado, and Kelly A Holmes, and Timothy R Geistlinger, and Iain R Hutcheson, and Robert I Nicholson, and Myles Brown, and Jie Jiang, and William J Howat, and Simak Ali, and Jason S Carroll
Post-transcriptional regulation of ERBB2 by miR26a/b and HuR confers resistance to tamoxifen in estrogen receptor-positive breast cancer cells.
August 2017, The Journal of biological chemistry,
Antoni Hurtado, and Kelly A Holmes, and Timothy R Geistlinger, and Iain R Hutcheson, and Robert I Nicholson, and Myles Brown, and Jie Jiang, and William J Howat, and Simak Ali, and Jason S Carroll
Expression of the oestrogen regulated pNR-2 mRNA in human breast cancer: relation to oestrogen receptor mRNA levels and response to tamoxifen therapy.
January 1990, British journal of cancer,
Antoni Hurtado, and Kelly A Holmes, and Timothy R Geistlinger, and Iain R Hutcheson, and Robert I Nicholson, and Myles Brown, and Jie Jiang, and William J Howat, and Simak Ali, and Jason S Carroll
Inhibition of oestradiol binding to oestrogen receptor proteins by a methyl-substituted analogue of tamoxifen.
June 1976, The Journal of endocrinology,
Antoni Hurtado, and Kelly A Holmes, and Timothy R Geistlinger, and Iain R Hutcheson, and Robert I Nicholson, and Myles Brown, and Jie Jiang, and William J Howat, and Simak Ali, and Jason S Carroll
Regulation of bradykinin B2-receptor expression by oestrogen.
August 1997, British journal of pharmacology,
Copied contents to your clipboard!